219 related articles for article (PubMed ID: 22336636)
1. Ischemia modified albumin: an oxidative stress marker in β-thalassemia major.
Awadallah SM; Atoum MF; Nimer NA; Saleh SA
Clin Chim Acta; 2012 May; 413(9-10):907-10. PubMed ID: 22336636
[TBL] [Abstract][Full Text] [Related]
2. The relationship between diabetic retinopathy and serum levels of ischemia-modified albumin and malondialdehyde.
Turk A; Nuhoglu I; Mentese A; Karahan SC; Erdol H; Erem C
Retina; 2011 Mar; 31(3):602-8. PubMed ID: 21273947
[TBL] [Abstract][Full Text] [Related]
3. Total antioxidant capacity and ischemia modified albumin in beta thalassemia.
Awadallah S; Al Arrayed K; Bahareth E; Saeed Z
Clin Lab; 2013; 59(5-6):687-91. PubMed ID: 23865371
[TBL] [Abstract][Full Text] [Related]
4. Association of haptoglobin phenotypes with ceruloplasmin ferroxidase activity in β-thalassemia major.
Awadallah SM; Nimer NA; Atoum MF; Saleh SA
Clin Chim Acta; 2011 May; 412(11-12):975-9. PubMed ID: 21315066
[TBL] [Abstract][Full Text] [Related]
5. The novel ischemia marker 'ischemia-modified albumin' is increased in normal pregnancies.
Guven S; Alver A; Mentese A; Ilhan FC; Calapoglu M; Unsal MA
Acta Obstet Gynecol Scand; 2009; 88(4):479-82. PubMed ID: 19235558
[TBL] [Abstract][Full Text] [Related]
6. Investigation of the possibility of using ischemia-modified albumin as a novel and early prognostic marker in cardiac arrest patients after cardiopulmonary resuscitation.
Turedi S; Gunduz A; Mentese A; Dasdibi B; Karahan SC; Sahin A; Tuten G; Kopuz M; Alver A
Resuscitation; 2009 Sep; 80(9):994-9. PubMed ID: 19581040
[TBL] [Abstract][Full Text] [Related]
7. Assessment of ischaemia-modified albumin level in patients with psoriasis.
Ozdemir M; Kiyici A; Balevi A; Mevlitoğlu I; Peru C
Clin Exp Dermatol; 2012 Aug; 37(6):610-4. PubMed ID: 22607558
[TBL] [Abstract][Full Text] [Related]
8. Obesity is an independent determinant of ischemia-modified albumin.
Mehmetoğlu I; Kurban S; Yerlikaya FH; Polat H
Obes Facts; 2012; 5(5):700-9. PubMed ID: 23108391
[TBL] [Abstract][Full Text] [Related]
9. Ischemia-modified albumin as a marker of vascular dysfunction and subclinical atherosclerosis in β-thalassemia major.
Adly AAM; ElSherif NHK; Ismail EAR; Ibrahim YA; Niazi G; Elmetwally SH
Redox Rep; 2017 Nov; 22(6):430-438. PubMed ID: 28288539
[TBL] [Abstract][Full Text] [Related]
10. Effect of chronic regular exercise on serum ischemia-modified albumin levels and oxidative stress in type 2 diabetes mellitus.
Kurban S; Mehmetoglu I; Yerlikaya HF; Gönen S; Erdem S
Endocr Res; 2011; 36(3):116-23. PubMed ID: 21736494
[TBL] [Abstract][Full Text] [Related]
11. Ischaemia-modified albumin levels in newborn jaundice before and after phototherapy.
Erdem SS; Kurban S; Altunhan H; Annagür A; Ors R; Yerlikaya FH; Gökçe R; Mehmetoğlu I
Cell Biochem Funct; 2011 Aug; 29(6):521-5. PubMed ID: 21735457
[TBL] [Abstract][Full Text] [Related]
12. Ischemia-modified albumin as an oxidative stress marker in preeclampsia.
Ustün Y; Engin-Ustün Y; Oztürk O; Alanbay I; Yaman H
J Matern Fetal Neonatal Med; 2011 Mar; 24(3):418-21. PubMed ID: 20617896
[TBL] [Abstract][Full Text] [Related]
13. Peroxidative stress and antioxidant enzymes in children with beta-thalassemia major.
Naithani R; Chandra J; Bhattacharjee J; Verma P; Narayan S
Pediatr Blood Cancer; 2006 Jun; 46(7):780-5. PubMed ID: 16317757
[TBL] [Abstract][Full Text] [Related]
14. Increased ischemia-modified albumin levels in patients with gastric cancer.
Fidan E; Mentese A; Kavgaci H; Orem A; Fidan S; Uzun A; Ozdemir F; Aydin F
Neoplasma; 2012; 59(4):393-7. PubMed ID: 22489694
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the levels of oxidative stress factors and ischemia modified albumin in the cord blood of smoker and non-smoker pregnant women.
Şahinli AS; Marakoğlu K; Kiyici A
J Matern Fetal Neonatal Med; 2012 Jul; 25(7):1064-8. PubMed ID: 21916812
[TBL] [Abstract][Full Text] [Related]
16. Antioxidant status in beta thalassemia major: a single-center study.
Waseem F; Khemomal KA; Sajid R
Indian J Pathol Microbiol; 2011; 54(4):761-3. PubMed ID: 22234105
[TBL] [Abstract][Full Text] [Related]
17. Serum ischemia modified albumin is a possible new marker of oxidative stress in phenylketonuria.
Keshavarzi F; Rastegar M; Vessal M; Rafiei Dehbidi G; Khorsand M; Ganjkarimi AH; Takhshid MA
Metab Brain Dis; 2018 Jun; 33(3):675-680. PubMed ID: 29270710
[TBL] [Abstract][Full Text] [Related]
18. Serum levels of ischemia modified albumin in overweight/obese postmenopausal women: a potential biomarker of atherosclerotic burden associated with oxidative stress.
Kazanis K; Dalamaga M; Kassi E; Nounopoulos C; Manolis AS; Merantzi G; Jullien G; Dionyssiou-Asteriou A
Maturitas; 2011 Oct; 70(2):182-7. PubMed ID: 21839592
[TBL] [Abstract][Full Text] [Related]
19. Ischemia modified albumin and carbonyl protein as potential biomarkers of protein oxidation in hemodialysis.
Albarello K; dos Santos GA; Bochi GV; Sangoi MB; Almeida TC; Paz da Silva JE; Garcia SC; Moresco RN
Clin Biochem; 2012 Apr; 45(6):450-4. PubMed ID: 22342921
[TBL] [Abstract][Full Text] [Related]
20. Ischemia-modified albumin in patients with hyperthyroidism and hypothyroidism.
Ma SG; Yang LX; Bai F; Xu W; Hong B
Eur J Intern Med; 2012 Sep; 23(6):e136-40. PubMed ID: 22863438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
